I  Accelerator

http://www.acceleratorcorp.com





     Office Locations:

1616 Eastlake Avenue East, Suite 200
Seattle, WA 98102
Phone: 206-957-7300
Fax: 206-957-7399

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Seed


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Accelerator Corporation, founded in 2003, is a privately-held biotechnology investment and development company located in Seattle and New York. Resources provided by Accelerator and its Affiliates - MPM Capital, ARCH Venture Partners, Alexandria Real Estate Equities, Inc., Versant Ventures, Amgen Ventures, OVP Venture Partners, and the Institute for Systems Biology - include committed investment capital, state-of-the-art facilities, world-class scientific and technical expertise and support, and experienced start-up management. Accelerator occupies an 18,000 square foot state-of-the-art space located within a 165,000 SF facility owned and developed by an affiliate of Alexandria Real Estate Equities, Inc. in the midst of the vibrant Eastlake life science cluster in Seattle. The facility includes a number of laboratory/office 'suites' as well as common space (reception, conference rooms, break room, etc.) and support infrastructure (autoclave/glass wash, DI water system, telecommunications/network, etc.). In the past nine years, twelve companies have been invested in through Accelerator. Five have emerged and raised follow on financings of more than $164 million. Three remain under management at Accelerator. In all, Accelerator companies have raised in excess of $221 million in initial and follow-on financings. Accelerator's investors have committed an additional $22.5 million to enable Accelerator to continue to identify, capitalize, and develop the next-generation of exciting emerging biotechnologies. In July of 2014, the firm announced the closing of Accelerator IV with $51.1 million in capital commitments.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Alice Chen Principal
    David McElligott Chief Scientific Officer
    David Schubert Venture Partner & Director of Innovation
    Lindsay Rayle CFO
    Thong Q. Le CEO

     

    Portfolio companies include:


      Acylin Therapeutics
        web link


      Allozyne
        web link


      ApoGen Biotechnologies
        web link


      Groove BioPharma
        web link


      Integrated Diagnostics
        web link


      Isocket
        web link


      Lodo Therapeutics
        web link


      Mirina
        web link


      OncoFactor
        web link


      PharmSelex
        web link


      Recodagen
        web link


      Theraclone Sciences
        web link


      VieVax


      VLST
        web link


      XORI
        web link


     

    Recent News:


      There is no recent news for Accelerator.